FABULINUS has been downloaded 170 times. In the last 30 days, the app was downloaded 1 times.
User Ratings
The app has no ratings yet.
App Information
FABULINUS is FREE to download. The APK download size is 48.18 MB. The latest version available is 1.0.57. The last update was on June 24, 2026.
Technical Requirements
The app has a content rating of Everyone. The app has been available on Google Play October 2023.
Description
This app is intended for use by participants in the FABULINUS study and requires an invitation and activation code from the study site to register. A 52-week randomized, double-blind, placebo-controlled, multi-center Phase 2b study with a 52-week blinded extension and an optional open-label extension—assessing the safety and efficacy of frexalimab, a CD40L-antagonist monoclonal antibody, for the preservation of pancreatic β-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy. This study has been reviewed and approved by the appropriate regulatory body, e.g. Institutional Review Board (IRB) or Independent Ethics Committee (IEC).
Key App Features: - Patient Onboarding – complete study app registration and education - Activities – on-demand study tasks and assessments are sent from the site to the participant - Dashboard – review overall progress in the study and current activities - Resources – view study information in the Learn section of the app - Profile – manage account details and app settings - Notifications – receive in-app reminders - Telehealth – conduct scheduled virtual visits with your study site
About THREAD: THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient.
Recent changes: Additional milestones and update to Study injection diary.
Get a detailed PDF report for FABULINUS with download trends, rating history,
and key performance statistics — useful for competitive research or tracking your own app.
Learn more
Are you the developer of this app? Join us for free to see more information about your app and learn how we can help you promote and earn money with your app.
Each subscription will automatically renew 3 days before the expiration date for
the same time period. Subscriptions can be cancelled at any time before the renewal.